Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001846478-23-000002
Filing Date
2023-08-25
Accepted
2023-08-25 16:22:42
Documents
1
Period of Report
2023-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1692994951.html 4  
1 FORM 4 wk-form4_1692994951.xml 4 8657
  Complete submission text file 0001846478-23-000002.txt   10212
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address
Gutwerg Ori (Reporting) CIK: 0001846478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 231208628